NR565/NR565 MID EXAM Advanced Pharmacology
Questions, Answers and Elaborate
Rationales(100% verified and correct answers )
GRADE A+ Chamberlain
1. A 62-year-old male with type 2 diabetes and hypertension presents with persistent blood
pressure readings of 150/92 mmHg despite lifestyle modification. Laboratory studies reveal
microalbuminuria and normal potassium levels, and renal function is stable at baseline.
Which medication should the nurse practitioner initiate to both control blood pressure and
slow progression of diabetic nephropathy?
A. Amlodipine
B. Lisinopril
C. Metoprolol
D. Hydrochlorothiazide
Rationale: ACE inhibitors such as lisinopril are first-line therapy in diabetic patients with
hypertension and albuminuria because they reduce intraglomerular pressure by blocking
conversion of angiotensin I to angiotensin II, thereby decreasing efferent arteriolar constriction
and slowing kidney damage progression. In addition to lowering systemic blood pressure, ACE
inhibitors reduce proteinuria and provide renal protective effects that calcium channel blockers,
beta blockers, and thiazide diuretics do not directly provide in diabetic nephropathy. Amlodipine,
metoprolol, and hydrochlorothiazide may lower blood pressure effectively, but they lack the
specific nephroprotective benefits demonstrated with ACE inhibitors in patients with diabetes
and microalbuminuria.
2. A 68-year-old female stabilized on warfarin therapy for atrial fibrillation is prescribed
trimethoprim-sulfamethoxazole for a urinary tract infection. Three days later her INR
increases significantly above therapeutic range without any change in diet or warfarin
dosage. What is the most likely mechanism responsible for this elevation in INR?
A. Enzyme induction increasing warfarin clearance
B. CYP2C9 inhibition decreasing warfarin metabolism
C. Reduced gastrointestinal absorption of warfarin
D. Increased renal excretion of warfarin
Rationale: Trimethoprim-sulfamethoxazole inhibits the CYP2C9 enzyme responsible for
metabolizing the more potent S-enantiomer of warfarin, leading to decreased hepatic breakdown
and increased circulating warfarin concentrations. Because warfarin has a narrow therapeutic
index, even modest inhibition of its metabolism can significantly increase INR and raise the
,patient’s risk for bleeding complications. Enzyme induction would lower INR rather than elevate
it, and warfarin is not primarily eliminated through renal excretion nor significantly affected by
reduced gastrointestinal absorption in this context.
3. A 74-year-old patient with heart failure with reduced ejection fraction is prescribed
spironolactone in addition to an ACE inhibitor and beta blocker. Baseline laboratory
results show mild chronic kidney disease but stable electrolytes at initiation. Which
laboratory parameter requires the most careful monitoring after starting this medication?
A. Serum sodium
B. Serum potassium
C. Hemoglobin
D. Fasting glucose
Rationale: Spironolactone is a potassium-sparing diuretic that antagonizes aldosterone receptors
in the distal nephron, decreasing sodium reabsorption while reducing potassium excretion, which
significantly increases the risk of hyperkalemia. Hyperkalemia can lead to life-threatening
cardiac arrhythmias, particularly in elderly patients and those with reduced renal function,
making close monitoring of serum potassium essential after initiation. Although sodium levels
may change slightly and other labs are important in overall care, potassium elevation is the most
clinically significant and potentially dangerous adverse effect associated with spironolactone
therapy.
4. A 55-year-old patient with a history of asthma is prescribed propranolol for migraine
prevention and develops worsening wheezing and shortness of breath shortly after
initiation. The nurse practitioner suspects that the medication’s receptor activity is
responsible for the respiratory symptoms. Which mechanism best explains this adverse
effect?
A. Beta-1 receptor blockade in cardiac tissue
B. Beta-2 receptor blockade in bronchial smooth muscle
C. Muscarinic receptor stimulation
D. Inhibition of renin release
Rationale: Propranolol is a nonselective beta blocker that blocks both beta-1 and beta-2
receptors, and inhibition of beta-2 receptors in bronchial smooth muscle prevents normal
bronchodilation, leading to bronchoconstriction. Patients with asthma rely on beta-2 mediated
bronchodilation to maintain airway patency, so blocking these receptors can precipitate
bronchospasm and respiratory distress. Cardioselective beta-1 blockers may be safer in
respiratory disease, but nonselective agents like propranolol are generally contraindicated in
patients with reactive airway conditions.
5. A 59-year-old patient with type 2 diabetes treated with metformin undergoes a contrast-
enhanced imaging study and subsequently develops acute kidney injury. The nurse
practitioner immediately discontinues metformin due to concern for a serious metabolic
,complication associated with drug accumulation. What is the primary reason metformin
must be held in this situation?
A. Increased risk of hypoglycemia
B. Increased risk of lactic acidosis
C. Increased risk of pancreatitis
D. Increased risk of hyperkalemia
Rationale: Metformin is excreted unchanged by the kidneys, and acute renal impairment can
lead to accumulation of the drug, increasing the risk of lactic acidosis, a rare but potentially fatal
metabolic condition characterized by elevated lactate and metabolic acidosis. Because iodinated
contrast can worsen renal function, guidelines recommend temporarily holding metformin before
and after contrast exposure until renal function is reassessed and stabilized. Hypoglycemia is
uncommon with metformin monotherapy since it does not stimulate insulin secretion, and
pancreatitis or hyperkalemia are not primary risks associated with this medication.
6. A 66-year-old female with hypothyroidism is started on levothyroxine therapy and
returns for follow-up evaluation after six weeks of treatment. She reports improved energy
but mild palpitations, and laboratory testing is ordered to assess therapeutic response and
guide dose adjustment. Which laboratory value is most appropriate to monitor for
determining adequate levothyroxine dosing?
A. Free T3
B. TSH
C. Total T4
D. Reverse T3
Rationale: Thyroid-stimulating hormone (TSH) is the most sensitive and reliable marker for
assessing adequacy of levothyroxine therapy because it reflects the negative feedback regulation
of circulating thyroid hormone at the level of the pituitary gland. When levothyroxine dosing is
appropriate, TSH levels normalize within the reference range, whereas suppressed TSH may
indicate overtreatment and risk for atrial fibrillation or bone loss. Free T3 and total T4 can
provide additional information but are not as sensitive as TSH for routine monitoring in primary
hypothyroidism.
7. A 72-year-old male with benign prostatic hyperplasia is prescribed tamsulosin and
reports dizziness when standing up shortly after starting therapy. The nurse practitioner
recognizes that this adverse effect is related to the drug’s mechanism of action on vascular
smooth muscle. Which pharmacologic property explains this patient’s symptoms?
A. Beta-1 receptor blockade
B. Alpha-1 receptor antagonism
C. Muscarinic receptor stimulation
D. Calcium channel inhibition
, Rationale: Tamsulosin is an alpha-1 adrenergic receptor antagonist that relaxes smooth muscle
in the prostate and bladder neck, improving urinary flow but also causing peripheral
vasodilation. This vasodilatory effect can lead to orthostatic hypotension, particularly when
therapy is initiated or doses are increased, resulting in dizziness upon standing. Beta-1 blockade
affects heart rate, and calcium channel inhibition or muscarinic stimulation do not explain the
characteristic postural hypotension associated with alpha-1 antagonists.
8. A patient with type 2 diabetes is prescribed a GLP-1 receptor agonist for improved
glycemic control and cardiovascular benefit. The patient asks how this medication lowers
blood glucose levels without causing frequent hypoglycemia. Which mechanism best
explains the action of GLP-1 receptor agonists?
A. Continuous insulin release regardless of glucose level
B. Glucose-dependent stimulation of insulin secretion
C. Direct inhibition of hepatic gluconeogenesis
D. Increased renal glucose excretion
Rationale: GLP-1 receptor agonists stimulate insulin secretion in a glucose-dependent manner,
meaning insulin release increases only when blood glucose levels are elevated, thereby reducing
the risk of hypoglycemia compared to sulfonylureas. They also slow gastric emptying and
suppress glucagon secretion, contributing to improved postprandial glucose control and weight
reduction. Continuous insulin release regardless of glucose level would increase hypoglycemia
risk, and increased renal glucose excretion is the mechanism of SGLT2 inhibitors rather than
GLP-1 agonists.
9. A 60-year-old patient with chronic pain is prescribed long-term opioid therapy and
develops constipation despite adequate hydration and fiber intake. The nurse practitioner
explains that this adverse effect is directly related to opioid receptor activity in the
gastrointestinal tract. What is the primary mechanism responsible for opioid-induced
constipation?
A. Increased gastric acid secretion
B. Decreased gastrointestinal motility via mu receptor activation
C. Enhanced intestinal water secretion
D. Inhibition of pancreatic enzymes
Rationale: Opioids activate mu receptors in the gastrointestinal tract, leading to decreased
peristalsis, increased smooth muscle tone, and prolonged transit time, which collectively result in
constipation. Unlike other adverse effects that may diminish with tolerance, opioid-induced
constipation often persists because the gastrointestinal tract does not develop significant
tolerance to opioid effects. Increased gastric acid or pancreatic enzyme inhibition are not central
mechanisms in opioid-related bowel dysfunction.
10. A 58-year-old patient with hyperlipidemia is prescribed atorvastatin and returns
complaining of diffuse muscle aches and weakness. The nurse practitioner considers a
Questions, Answers and Elaborate
Rationales(100% verified and correct answers )
GRADE A+ Chamberlain
1. A 62-year-old male with type 2 diabetes and hypertension presents with persistent blood
pressure readings of 150/92 mmHg despite lifestyle modification. Laboratory studies reveal
microalbuminuria and normal potassium levels, and renal function is stable at baseline.
Which medication should the nurse practitioner initiate to both control blood pressure and
slow progression of diabetic nephropathy?
A. Amlodipine
B. Lisinopril
C. Metoprolol
D. Hydrochlorothiazide
Rationale: ACE inhibitors such as lisinopril are first-line therapy in diabetic patients with
hypertension and albuminuria because they reduce intraglomerular pressure by blocking
conversion of angiotensin I to angiotensin II, thereby decreasing efferent arteriolar constriction
and slowing kidney damage progression. In addition to lowering systemic blood pressure, ACE
inhibitors reduce proteinuria and provide renal protective effects that calcium channel blockers,
beta blockers, and thiazide diuretics do not directly provide in diabetic nephropathy. Amlodipine,
metoprolol, and hydrochlorothiazide may lower blood pressure effectively, but they lack the
specific nephroprotective benefits demonstrated with ACE inhibitors in patients with diabetes
and microalbuminuria.
2. A 68-year-old female stabilized on warfarin therapy for atrial fibrillation is prescribed
trimethoprim-sulfamethoxazole for a urinary tract infection. Three days later her INR
increases significantly above therapeutic range without any change in diet or warfarin
dosage. What is the most likely mechanism responsible for this elevation in INR?
A. Enzyme induction increasing warfarin clearance
B. CYP2C9 inhibition decreasing warfarin metabolism
C. Reduced gastrointestinal absorption of warfarin
D. Increased renal excretion of warfarin
Rationale: Trimethoprim-sulfamethoxazole inhibits the CYP2C9 enzyme responsible for
metabolizing the more potent S-enantiomer of warfarin, leading to decreased hepatic breakdown
and increased circulating warfarin concentrations. Because warfarin has a narrow therapeutic
index, even modest inhibition of its metabolism can significantly increase INR and raise the
,patient’s risk for bleeding complications. Enzyme induction would lower INR rather than elevate
it, and warfarin is not primarily eliminated through renal excretion nor significantly affected by
reduced gastrointestinal absorption in this context.
3. A 74-year-old patient with heart failure with reduced ejection fraction is prescribed
spironolactone in addition to an ACE inhibitor and beta blocker. Baseline laboratory
results show mild chronic kidney disease but stable electrolytes at initiation. Which
laboratory parameter requires the most careful monitoring after starting this medication?
A. Serum sodium
B. Serum potassium
C. Hemoglobin
D. Fasting glucose
Rationale: Spironolactone is a potassium-sparing diuretic that antagonizes aldosterone receptors
in the distal nephron, decreasing sodium reabsorption while reducing potassium excretion, which
significantly increases the risk of hyperkalemia. Hyperkalemia can lead to life-threatening
cardiac arrhythmias, particularly in elderly patients and those with reduced renal function,
making close monitoring of serum potassium essential after initiation. Although sodium levels
may change slightly and other labs are important in overall care, potassium elevation is the most
clinically significant and potentially dangerous adverse effect associated with spironolactone
therapy.
4. A 55-year-old patient with a history of asthma is prescribed propranolol for migraine
prevention and develops worsening wheezing and shortness of breath shortly after
initiation. The nurse practitioner suspects that the medication’s receptor activity is
responsible for the respiratory symptoms. Which mechanism best explains this adverse
effect?
A. Beta-1 receptor blockade in cardiac tissue
B. Beta-2 receptor blockade in bronchial smooth muscle
C. Muscarinic receptor stimulation
D. Inhibition of renin release
Rationale: Propranolol is a nonselective beta blocker that blocks both beta-1 and beta-2
receptors, and inhibition of beta-2 receptors in bronchial smooth muscle prevents normal
bronchodilation, leading to bronchoconstriction. Patients with asthma rely on beta-2 mediated
bronchodilation to maintain airway patency, so blocking these receptors can precipitate
bronchospasm and respiratory distress. Cardioselective beta-1 blockers may be safer in
respiratory disease, but nonselective agents like propranolol are generally contraindicated in
patients with reactive airway conditions.
5. A 59-year-old patient with type 2 diabetes treated with metformin undergoes a contrast-
enhanced imaging study and subsequently develops acute kidney injury. The nurse
practitioner immediately discontinues metformin due to concern for a serious metabolic
,complication associated with drug accumulation. What is the primary reason metformin
must be held in this situation?
A. Increased risk of hypoglycemia
B. Increased risk of lactic acidosis
C. Increased risk of pancreatitis
D. Increased risk of hyperkalemia
Rationale: Metformin is excreted unchanged by the kidneys, and acute renal impairment can
lead to accumulation of the drug, increasing the risk of lactic acidosis, a rare but potentially fatal
metabolic condition characterized by elevated lactate and metabolic acidosis. Because iodinated
contrast can worsen renal function, guidelines recommend temporarily holding metformin before
and after contrast exposure until renal function is reassessed and stabilized. Hypoglycemia is
uncommon with metformin monotherapy since it does not stimulate insulin secretion, and
pancreatitis or hyperkalemia are not primary risks associated with this medication.
6. A 66-year-old female with hypothyroidism is started on levothyroxine therapy and
returns for follow-up evaluation after six weeks of treatment. She reports improved energy
but mild palpitations, and laboratory testing is ordered to assess therapeutic response and
guide dose adjustment. Which laboratory value is most appropriate to monitor for
determining adequate levothyroxine dosing?
A. Free T3
B. TSH
C. Total T4
D. Reverse T3
Rationale: Thyroid-stimulating hormone (TSH) is the most sensitive and reliable marker for
assessing adequacy of levothyroxine therapy because it reflects the negative feedback regulation
of circulating thyroid hormone at the level of the pituitary gland. When levothyroxine dosing is
appropriate, TSH levels normalize within the reference range, whereas suppressed TSH may
indicate overtreatment and risk for atrial fibrillation or bone loss. Free T3 and total T4 can
provide additional information but are not as sensitive as TSH for routine monitoring in primary
hypothyroidism.
7. A 72-year-old male with benign prostatic hyperplasia is prescribed tamsulosin and
reports dizziness when standing up shortly after starting therapy. The nurse practitioner
recognizes that this adverse effect is related to the drug’s mechanism of action on vascular
smooth muscle. Which pharmacologic property explains this patient’s symptoms?
A. Beta-1 receptor blockade
B. Alpha-1 receptor antagonism
C. Muscarinic receptor stimulation
D. Calcium channel inhibition
, Rationale: Tamsulosin is an alpha-1 adrenergic receptor antagonist that relaxes smooth muscle
in the prostate and bladder neck, improving urinary flow but also causing peripheral
vasodilation. This vasodilatory effect can lead to orthostatic hypotension, particularly when
therapy is initiated or doses are increased, resulting in dizziness upon standing. Beta-1 blockade
affects heart rate, and calcium channel inhibition or muscarinic stimulation do not explain the
characteristic postural hypotension associated with alpha-1 antagonists.
8. A patient with type 2 diabetes is prescribed a GLP-1 receptor agonist for improved
glycemic control and cardiovascular benefit. The patient asks how this medication lowers
blood glucose levels without causing frequent hypoglycemia. Which mechanism best
explains the action of GLP-1 receptor agonists?
A. Continuous insulin release regardless of glucose level
B. Glucose-dependent stimulation of insulin secretion
C. Direct inhibition of hepatic gluconeogenesis
D. Increased renal glucose excretion
Rationale: GLP-1 receptor agonists stimulate insulin secretion in a glucose-dependent manner,
meaning insulin release increases only when blood glucose levels are elevated, thereby reducing
the risk of hypoglycemia compared to sulfonylureas. They also slow gastric emptying and
suppress glucagon secretion, contributing to improved postprandial glucose control and weight
reduction. Continuous insulin release regardless of glucose level would increase hypoglycemia
risk, and increased renal glucose excretion is the mechanism of SGLT2 inhibitors rather than
GLP-1 agonists.
9. A 60-year-old patient with chronic pain is prescribed long-term opioid therapy and
develops constipation despite adequate hydration and fiber intake. The nurse practitioner
explains that this adverse effect is directly related to opioid receptor activity in the
gastrointestinal tract. What is the primary mechanism responsible for opioid-induced
constipation?
A. Increased gastric acid secretion
B. Decreased gastrointestinal motility via mu receptor activation
C. Enhanced intestinal water secretion
D. Inhibition of pancreatic enzymes
Rationale: Opioids activate mu receptors in the gastrointestinal tract, leading to decreased
peristalsis, increased smooth muscle tone, and prolonged transit time, which collectively result in
constipation. Unlike other adverse effects that may diminish with tolerance, opioid-induced
constipation often persists because the gastrointestinal tract does not develop significant
tolerance to opioid effects. Increased gastric acid or pancreatic enzyme inhibition are not central
mechanisms in opioid-related bowel dysfunction.
10. A 58-year-old patient with hyperlipidemia is prescribed atorvastatin and returns
complaining of diffuse muscle aches and weakness. The nurse practitioner considers a
